Anti-rheumatic DrugsE. C. Huskisson |
From inside the book
Results 1-3 of 82
Page 135
... significantly more improved by diclofenac sodium . In other assessments the active drugs were similarly and significantly better than placebo except for grip strength and erythrocyte sedimentation rate ( ESR ) . Miehlke ( 1976a , b ) ...
... significantly more improved by diclofenac sodium . In other assessments the active drugs were similarly and significantly better than placebo except for grip strength and erythrocyte sedimentation rate ( ESR ) . Miehlke ( 1976a , b ) ...
Page 226
... significantly greater than change with gold . significantly so only for IgA . IgG was significantly reduced only in the gold group ( Table 12 ) . No patients were permanently withdrawn from the fenclofenac group as a result of side ...
... significantly greater than change with gold . significantly so only for IgA . IgG was significantly reduced only in the gold group ( Table 12 ) . No patients were permanently withdrawn from the fenclofenac group as a result of side ...
Page 288
... significantly better than ASA ; the 600 mg dose of indoprofen , though it did not differ significantly from ASA , was more frequently preferred to the latter both by doctors and patients . A statistically significant dose - response ...
... significantly better than ASA ; the 600 mg dose of indoprofen , though it did not differ significantly from ASA , was more frequently preferred to the latter both by doctors and patients . A statistically significant dose - response ...
Contents
THE MODE OF ACTION OF ANTIINFLAMMATORY DRUGS WHICH PREVENT | 11 |
CLINICALLY SIGNIFICANT DRUG INTERACTIONS WITH ANTIRHEUMATIC DRUGS 32 | 37 |
ASPIRIN AND THE SALICYLATES 55 | 55 |
Copyright | |
34 other sections not shown
Common terms and phrases
acid action activity acute administration adverse agents analgesic anti-inflammatory appears aspirin associated blood cause cells cent changes chronic clinical Clinical Pharmacology compared comparison compounds concentrations controlled daily demonstrated developed diclofenac sodium diflunisal disease dosage dose double-blind drugs efficacy et al evidence excretion fenclofenac Figure four function gastrointestinal given gold half-life human Huskisson ibuprofen improvement incidence increased indicated indomethacin indoprofen inflammation inflammatory inhibition injection interaction International joint Journal less levamisole levels measured Medical Medicine mg/kg months naproxen normal observed occur oral orgotein pain patients penicillamine period phenylbutazone piroxicam placebo plasma platelet potent produced prostaglandin rats reactions receiving reduced renal reported Research response rheumatoid arthritis Rheumatology salicylate serum severe showed shown side effects significant significantly similar single sodium subjects sulindac symptoms synovial fluid Table tests therapeutic therapy tion tissue tolerated tolmetin toxicity treated treatment trial weeks